This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Reactions Weekly

April 2016, Volume 1598, Issue 1, pp 49–49 | Cite as

Brentuximab vedotin

Neuropathy, fatigue and pruritus: 4 case reports

Case report

First Online: 23 April 2016

This is a preview of subscription content, to check access.

Reference

Talpur R, et al. A Single-Center Experience with Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia 16: e15-e19, No. 2, Feb 2016. Available from: URL: http://doi.org/10.1016/j.clml.2015.11.013 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

About this article

Cite this article as:: Reactions Weekly (2016) 1598: 49. https://doi.org/10.1007/s40278-016-16706-6

DOI https://doi.org/10.1007/s40278-016-16706-6
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations